You are here

Amgen

FDA Approves Amgen's Groundbreaking LUMAKRAS Combination Therapy for Colorectal Cancer Treatment

Stock Titan

Fri, 01/17/25 - 11:21 am

metastatic colorectal cancer

HER-positive colorectal cancer

JP Morgan 2025: reduced dosing and expanded manufacturing paving way for Amgen’s obesity entrance

Clinical Trials Arena

Tue, 01/14/25 - 09:54 am

CytomX lays off 40% of staff, questions future of Amgen-partnered T-cell engager

Fierce Biotech

Tue, 01/7/25 - 11:14 am

CytomX Therapeutics

How pharma was instrumental in President Jimmy Carter’s global health efforts

Pharma Voice

Fri, 01/3/25 - 09:57 am

Viridian Stock Flashes A Bullish Sign In Its Eye-Disease Battle With Amgen

Investors Business Daily

Mon, 12/16/24 - 11:30 am

Viridian Therapeutics

thyroid eye disease

BeiGene inks $150M deal to follow cancer combo trail blazed by Amgen and Ideaya

Fierce Biotech

Fri, 12/13/24 - 11:41 am

Amgen rolls out $1B investment to build new drug substance plant in NC's biopharma hotbed

Fierce Pharma

Thu, 12/5/24 - 11:33 am

drug manufacturing

Coherus, sharpening immuno-oncology focus, sells another biosimilar for over $500M

BioPharma Dive

Wed, 12/4/24 - 10:59 am

Coherus Biosciences

immuno-oncology

Why Amgen's Weight Loss Result Is a Win for Eli Lilly

Motley Fool

Wed, 11/27/24 - 11:30 am

Amgen says obesity drug caused up to 20% weight loss after a year, but shares drop 10%

CNBC

Tue, 11/26/24 - 11:08 am

Amgen picks prolific biotech founder Chang as new top scientist

BioPharma Dive

Thu, 11/21/24 - 11:38 am

Amgen speaks out about bone density concerns with obesity drug

Clinical Trials Arena

Thu, 11/14/24 - 10:06 am

BMS, Merck, Amgen and more must look to M&A to offset looming patent lapses: Leerink

Fierce Pharma

Wed, 11/13/24 - 09:49 pm

Bristol Myers Squibb

Hidden data on obesity prospect wipe $12B off Amgen market cap

Fierce Biotech

Wed, 11/13/24 - 11:10 am

clinical trials

AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial

Clinical Trials Arena

Fri, 11/8/24 - 11:34 am

clinical trials

chronic rhinosinusitis with nasal polyps

Amgen reaps Horizon buyout rewards in Q3 as it gears up for key biosim launches

Fierce Pharma

Thu, 10/31/24 - 09:43 am

Amgen Whets Investors’ Appetites for MariTide Obesity Data by End of Year

BioSpace

Thu, 10/31/24 - 09:42 am

Regeneron loses bid to block Amgen's Eylea biosimilar launch in US

Reuters

Tue, 10/22/24 - 11:30 pm

FDA Pushes Back PDUFA Dates for Amgen and Intercept

BioSpace

Fri, 10/18/24 - 11:28 am

colorectal cancer

Intercept Pharma

primary biliary cholangitis

Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.

BioPharma Dive

Fri, 10/11/24 - 11:10 am

Skye Bioscience

Pages